OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
PharmAthene, a biodefense company, announced that it has terminated its definitive merger agreement with US-based Theraclone Sciences with consent from Theraclone. The agreement provided for the merger of a wholly-owned subsidiary of ...
US-based pharmaceutical firm Egalet has entered into a definitive collaboration and license agreement with Japan-based Shionogi for the development and commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates ...
Tags: Egalet, Product Candidates
BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...
Transgene has received a sub-award from Emergent BioSolutions (EBS) under its existing grant of $5m from the US National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), to advance ...
Tags: Transgene, NIH Funding
US-based iCeutica announced that its partner Iroko Pharmaceuticals has received the US Food and Drug Administration (FDA) approval to market ZORVOLEX (diclofenac) capsules, a non-steroidal anti-inflammatory drug (NSAID) that utilizes ...
US-based clinical stage biopharmaceutical firm Heat Biologics has filed an investigational new drug application (NDA) with the US Food and Drug Administration (FDA) for its second product candidate, HS-410, which will be evaluated in ...
US-based biotechnology company BioTime and its subsidiary LifeMap Sciences have entered into a definitive data mining collaboration agreement. Under the agreement, BioTime will use LifeMap's computer-based tools to extract information ...
Tags: biotechnology company, PureStem progenitor cell, biotechnology
Amgen has licensed ImmunoGen's Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics for an undisclosed amount. ImmunoGen president and CEO Daniel Junius said major healthcare companies are interested in developing ...
Tags: anticancer therapeutics, healthcare companies, healthcare, ImmunoGen
Polaris Financial Technology Ltd., a leading global Financial Technology Company, today announced that Gartner, Inc. has positioned Polaris FT in the Leaders Quadrant of the recently released 'Magic Quadrant for International Retail Core ...
Tags: Polaris Financial Technology, Gartner, banking, finance service
Pfizer and Protalix BioTherapeutics have announced FDA approval of Elelyso (taliglucerase alfa) for injection to treat type 1 Gaucher disease. Elelyso, derived from ProCellEx, is an enzyme replacement therapy (ERT) for the long-term ...
Tags: Protalix/Pfizer Gaucher Drug, Pfizer and Protalix BioTherapeutics
Alitair Pharmaceuticals has gained a notice of allowance from the US Patent and Trademark Office for its ion exchange resin platform drug delivery technology, REA. Alitair has out-licensed two product candidates utilizing its REA platform ...
Tags: Alitair Pharmaceuticals, REA Drug Delivery Technology, US Patent
The US Patent and Trademark Office(USPTO)has granted two new patents including Patent No.8,252,328 and Patent No.8,252,329 to AcelRx Pharmaceuticals'small-volume oral transmucosal dosage forms. The 8,252,328 patent covers delivery of ...
Tags: two new patents, 328, Patent No.8, 252, 329, AcelRx Pharmaceuticals
Liquidia Technologies has initiated multi-year product development collaboration with GlaxoSmithKline (GSK). Under the collaboration, GSK acquired exclusive rights to research and develop certain vaccine and inhaled product candidates ...